Home Industries Market Insights About Us Publisher Contact us

2024-2031 Global Pharmacovigilance (PV) Market Report - Production and Consumption Professional Analysis

ReportID: 555963

|

Published Date: 2024/07/06

|

No. of Pages: 165

|

Categories: IT & Telecommunication

|

Format :

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The focus of pharmacovigilance is on ADR (adverse drug reactions) and drug toxicity. The pharmacovigilance market comprises of all types of adverse events reporting conducted during clinical trials in hospitals, pharmacies, and other healthcare sectors.
This report elaborates the market size, market characteristics, and market growth of the Pharmacovigilance (PV) industry, and breaks down according to the type, application, and consumption area of Pharmacovigilance (PV). The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Pharmacovigilance (PV) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Pharmacovigilance (PV) market covered in Chapter 13:
Wipro Limited
Accenture
IBM
ICON PLC
PAREXEL International Corporation
Cognizant
Foresight Group International AG
United BioSource Corporation
IT Clinical
Capgemini
ArisGlobal
BioClinica
Laboratory Corporation of America Holdings
TAKE Solutions Ltd

In Chapter 6, on the basis of types, the Pharmacovigilance (PV) market from 2015 to 2025 is primarily split into:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining

In Chapter 7, on the basis of applications, the Pharmacovigilance (PV) market from 2015 to 2025 covers:
Hospitals
Pharmaceutical Companies
Other End Users

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Request For TOC

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Price

Single User

US$3000

Multi User

US$4200

Corporate User

US$5100

Excel Datapack

US$1500

Download Sample Report

Kindly share your specific requirement (if any)
970580f357b66011f3ad9bfd8fd4652a.png

2024-2031 Global Pharmacovigilance (PV) Market Report - Production and Consumption Professional Analysis